https://sclerodermanews.com/wp-content/uploads/videos/Sequence04.mp4 Scleroderma News correspondent Dr. Ana de Barros conducts an exclusive interview with Dr. Mihaela Ianosev, GlaxoSmithKline.
Isaura Santos
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Isaura Santos
https://sclerodermanews.com/wp-content/uploads/videos/Entrevista02.mp4 Scleroderma News correspondent Dr. Ana de Barros conducts an exclusive interview with Dr. Colin Meyer, Reata Pharmaceuticals.
Digestive System Involvement in Scleroderma
In this video from the Scleroderma Foundation, learn from Dinesh Khanna, MD, MS, about the gut involvement (also called…
Three leading organizations focused on scleroderma advocacy and research are partnering during June’s Scleroderma Awareness Month in order to boost awareness…
Bob Saget will once again host the 34th Cool Comedy – Hot Cuisine gala to benefit the Scleroderma Research Foundation (SRF). It will be…
Fibrocell Science, Inc., an autologous gene and cell therapy firm developing first-in-class treatments to address scleroderma and connective tissue-related diseases, recently announced that…
The Strategic Pharma-Academic Research Consortium for Translational Medicine has announced it is providing new grants that will support research into autoimmune diseases worth $1.9…
Fibrocell Science Reports First Quarter 2015 Financial And Operating Results On Friday, May 8, 2015
Fibrocell Science, Inc., a company focused on autologous cell and gene therapy that is developing top treatments to address rare and life-threatening skin and…
Cytori Therapeutics, Inc. recently announced an FDA approval that will allow them to expand the number of sites in the…
Cytori Therapeutics, Inc. recently announced that the European Medicines Agency’s Committee for Orphan Medicinal Products (COMP) has…